Profound Medical PROF
5.76
0.16
2.86%
as of 25 Sep
- Market cap
- $204.6M
- P/E
- 0.0×
Follow PROF
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 0.00 | 31.43 | 48.68 | 33.44 | 34.45 | 23.39 | 17.42 | 14.78 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | 0.00 | 0.00 | (8.69) | (47.75) | (45.48) | (34.78) | (22.98) | (31.64) | (36.24) |
P/B ratio |
— | 0.00 | 0.00 | 29.38 | 3.65 | 2.85 | 4.43 | 5.39 | 3.08 | 3.58 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 3.83 | 3.00 | 4.48 | 5.48 | 3.09 | 3.59 |
EV/Sales |
— | 0.00 | 0.00 | 30.05 | 37.43 | 23.87 | 28.56 | 20.74 | 12.71 | 11.63 |
EV/EBITDA |
— | 0.00 | 0.00 | 30.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 0.00 | 0.00 | 0.00 | (13.29) | (7.34) | (7.40) | (6.60) | (5.79) | (4.90) |
EV/FCF |
— | 0.00 | 0.00 | 0.00 | (13.29) | (7.15) | (7.23) | (6.43) | (5.65) | (4.82) |
Quick Ratio |
4.26 | 1.45 | 4.30 | 2.20 | 18.99 | 16.50 | 12.63 | 5.26 | 9.44 | 11.02 |
Current Ratio |
4.54 | 1.64 | 4.81 | 2.77 | 20.32 | 18.56 | 14.82 | 6.58 | 10.52 | 12.52 |
Net Debt/EBITDA |
0.89 | 0.36 | 1.00 | 0.42 | 4.75 | 2.32 | 1.29 | 0.69 | 1.56 | 1.36 |
Debt/Assets |
28.64% | 0.00% | 0.00% | 30.39% | 1.61% | 1.58% | 11.14% | 16.16% | 6.64% | 5.81% |
Debt/Equity |
0.46 | 0.37 | 0.45 | 0.64 | 0.02 | 0.02 | 0.14 | 0.23 | 0.08 | 0.07 |
Asset Turnover |
0.00 | 0.45 | 0.00 | 0.28 | 0.11 | 0.07 | 0.09 | 0.13 | 0.19 | 0.22 |
Operating CF/Net income |
0.89 | 0.79 | 0.88 | 0.99 | 0.95 | 0.73 | 0.90 | 0.80 | 0.84 | 0.90 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.13) | (0.23) | (0.32) | 0.00 | 0.00 | 0.00 | (0.43) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (108.45%) | (135.03%) | (98.84%) | (89.68%) | (38.71%) | (34.50%) | (43.23%) | (68.06%) | (60.70%) | (67.12%) | |
| (60.69%) | (171.60%) | 0.00% | (101.28%) | (32.11%) | (32.08%) | (37.92%) | (52.27%) | (48.72%) | (57.64%) | |
ROIC |
0.00% | 0.00% | 0.00% | (107.00%) | (77.98%) | (127.61%) | (158.59%) | (147.81%) | (203.16%) | (230.01%) |
Return on Tangible Assets |
(88.33%) | (218.79%) | (66.45%) | (100.75%) | (23.05%) | (41.62%) | (48.81%) | (77.73%) | (44.21%) | (60.20%) |
Average Days of Receivables |
0.00 | 334.27 | 444.08 | 289.45 | 371.35 | 74.99 | 346.59 | 369.51 | 240.77 | 163.25 |
Research and Development Expense of Revenue |
0.00% | 192.08% | 403.70% | 225.13% | 135.71% | 222.28% | 219.88% | 200.36% | 158.85% | 127.94% |
Selling, General and Administrative Expense of Revenue |
0.00% | 178.42% | 413.02% | 189.20% | 170.11% | 261.40% | 268.42% | 257.52% | 216.61% | 199.10% |
Intangible Assets out of Total Assets |
0.01 | 0.00 | 0.00 | 0.17 | 0.04 | 0.05 | 0.01 | 0.01 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 30.33% | 41.32% | 104.83% | 63.43% | 47.46% | 24.17% | 34.10% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.05 | 0.25 | 0.31 | 0.22 | 0.17 | 0.32 | 0.27 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (536.96%) | (562.32%) | (7.49%) | (5.93%) | (13.36%) | (12.49%) | (16.98%) | (14.91%) | (17.92%) |
Free Cash Flow Yield |
— | 0.00% | 0.00% | 0.00% | (5.79%) | (9.99%) | (11.47%) | (13.78%) | (12.93%) | (16.33%) |
Revenue per Share |
0.00 | 0.64 | 0.19 | 0.38 | 0.42 | 0.34 | 0.32 | 0.34 | 0.43 | 0.53 |
Operating CF per Share |
(2.59) | (1.94) | (1.34) | (1.36) | (1.19) | (1.09) | (1.24) | (1.07) | (0.95) | (1.26) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.02) | (0.02) | (0.03) | 0.00 | 0.00 | 0.00 | (0.01) |
Free Cash Flow per Share |
(2.59) | (1.94) | (1.34) | (1.37) | (1.21) | (1.12) | (1.24) | (1.07) | (0.95) | (1.27) |
Cash per Share |
3.72 | 1.45 | 2.25 | 1.33 | 4.85 | 3.28 | 2.23 | 1.24 | 2.22 | 1.98 |
Shareholders Equity per Share |
2.65 | 1.84 | 1.95 | 1.29 | 5.63 | 3.94 | 2.50 | 1.47 | 2.44 | 2.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.65 | 1.84 | 1.95 | 1.29 | 5.63 | 3.94 | 2.50 | 1.47 | 2.44 | 2.20 |
Free Cash Flow |
(10.74) | (11.88) | (13.45) | (15.24) | (20.92) | (22.95) | (25.80) | (22.61) | (23.45) | (38.45) |
Working Capital |
12.99 | 5.50 | 22.09 | 14.58 | 92.93 | 72.97 | 57.84 | 35.53 | 62.50 | 70.01 |
Capital Expenditures |
(0.81) | (0.37) | — | (0.19) | (0.35) | (0.59) | — | — | — | (0.24) |
Net Current Asset Value |
10.09 | 3.09 | 13.23 | 7.12 | 90.49 | 70.97 | 49.61 | 29.16 | 59.25 | 65.05 |
EV/EBIT |
— | 0.00 | 0.00 | 30.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.05 | 0.05 | 0.09 | 0.00 | 0.00 | 0.00 | 0.02 |
Net Profit Margin |
0.00% | (383.77%) | (797.87%) | (364.69%) | (296.03%) | (446.66%) | (429.11%) | (393.43%) | (260.45%) | (264.44%) |
Price to Operating Income |
— | 0.00 | 0.00 | 31.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.51 | 1.39 | 2.87 | 1.79 | 2.38 | 1.78 | 1.02 | 2.20 | 0.80 |
Cash ROIC |
(36.40%) | (54.39%) | (28.15%) | (40.66%) | (11.72%) | (15.52%) | (25.26%) | (36.44%) | (19.90%) | (29.78%) |
Accounts Receivable Turnover |
0.00 | 2.07 | 0.65 | 1.48 | 1.36 | 1.55 | 1.72 | 1.06 | 1.49 | 2.26 |
Accounts Payable Turnover |
0.05 | 1.16 | 0.38 | 0.60 | 1.20 | 1.20 | 1.40 | 1.99 | 3.34 | 3.27 |
Inventory Turnover |
0.19 | 4.29 | 0.69 | 0.56 | 0.85 | 0.62 | 0.48 | 0.39 | 0.57 | 0.67 |
Average Days of Payables |
3,457.55 | 475.41 | 800.64 | 619.52 | 322.31 | 296.02 | 202.74 | 109.36 | 131.95 | 121.25 |
Days of Inventory on Hand |
813.54 | 133.89 | 743.18 | 750.46 | 508.05 | 690.07 | 791.93 | 883.61 | 581.21 | 639.08 |
Average Receivables |
1.89 | 1.89 | 2.96 | 2.82 | 5.37 | 4.42 | 3.88 | 6.82 | 7.17 | 7.12 |
Average Payables |
2.69 | 2.69 | 3.47 | 2.95 | 3.21 | 3.28 | 2.61 | 1.45 | 1.09 | 1.44 |
Average Inventory |
0.73 | 0.73 | 1.91 | 3.17 | 4.50 | 6.37 | 7.68 | 7.47 | 6.40 | 7.02 |
Average Assets |
19.93 | 8.78 | 0.00 | 15.03 | 67.33 | 95.69 | 75.60 | 54.19 | 57.10 | 73.85 |
Average Common Equity |
11.15 | 11.15 | 15.45 | 16.97 | 55.86 | 88.98 | 66.31 | 41.61 | 45.82 | 63.43 |
Columns are period end dates